Journal
FUTURE ONCOLOGY
Volume 5, Issue 1, Pages 43-50Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/14796694.5.1.43
Keywords
anchorage independence; biomarkers; IGF-1 receptor; IRS-1; metastases
Categories
Ask authors/readers for more resources
The type 1 IGF receptor (IGF-IR) is activated by two ligands, IGF-1 and IGF-2, and by insulin at supraphysiological concentrations. It plays a significant role in the growth of normal and abnormal cells, and antibodies against the IGF-IR are now in clinical trials. Targeting of the IGF-IR in cancer cells (by antibodies or other means) can be improved by the appropriate select ion of responsive tumors. This review focuses on the optimization of IGF-IR targeting in human cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available